Human CYP2C19,High-Reductase

• UNSPSC Description:

  Human CYP2C19, High-Reductase, a recombinant CYP2C19, is a member of the CYP enzyme family. CYP2C19 catalyzes metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs[1].

• Target Antigen:

  Cytochrome P450

• Type:

  Enzyme

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/human-cyp2c19-high-reductase.html

• Smiles:

  [Human CYP2C19,High-Reductase]

• References & Citations:

  [1]Vignaux PA, et al. Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides. Chem Res Toxicol. 2023 Sep 18;36(9):1451-1455.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported